Unmasking Hidden Risks in Herbal Weight-Loss Supplements: LC–MS/MS - Based Detection of Sibutramine Adulteration for Consumer Safety Assessment
Objectives Herbal weight-loss supplements are widely perceived as safe alternatives to synthetic drugs; however, illegal adulteration with undeclared pharmaceuticals remains a significant public health concern. Sibutramine, withdrawn from the market because of serious cardiovascular risks, is one of the most frequently detected adulterants. This study aimed to develop and validate a sensitive liquid chromatography–tandem mass spectrometry (LC–MS/MS) method to detection of sibutramine in herbal dietary supplements, and to evaluate the presence of sibutramine in commercially available some of the selected products. Materials and Methods We analyzed sibutramine by ultra high-performance LC–MS/MS using a triple quadrupole mass spectrometer with electrospray ionization in multiple reaction monitoring (MRM) mode. Identification was based on the protonated precursor ion ( m/z 280) and characteristic product-ion transitions. The method was validated for linearity, limits of detection and quantification, recovery, accuracy, precision, robustness, and matrix effects in accordance with internationally accepted bioanalytical validation guidelines. Results The method demonstrated excellent linearity over the range of 5–500 µg/L (r 2 = 0.99987), with detection and quantification limits of 0.82 µg/L and 2.73 µg/L, respectively. Validation demonstrated satisfactory accuracy, precision, recovery, robustness, and negligible matrix effects, confirming the method’s suitability for routine analysis. Analysis of 17 commercially available herbal weight-loss supplements revealed the presence of sibutramine in 15 samples (88%), with concentrations ranging from trace levels to substantial amounts, indicating widespread adulteration. Conclusion The validated LC–MS/MS method provides a rapid, sensitive, and reliable approach for routine monitoring of sibutramine in herbal dietary supplements. The high prevalence of sibutramine detected in marketed products highlights the persistent problem of illegal adulteration and underscores the need for continuous market surveillance, stricter regulatory enforcement, and routine analytical screening to safeguard public health and ensure product quality.
Authors
- Mustafa Abdullah Yılmaz (ORCID: https://orcid.org/0000-0002-4090-7227)
- Alev Önder (ORCID: https://orcid.org/0000-0002-9088-1045)
- Sibel YILMAZ
Institutions
- Dicle University (TR)
- Ankara University (TR)
Publication Details
- Journal
- Turkish Journal of Pharmaceutical Sciences
- Published
- 2026-11-18
- DOI
- https://doi.org/10.4274/tjps.galenos.2026.45710
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00